Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy

Published:2011-01 Issue:1 Volume:17 Page:141-146
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wood William A.,Whitley Julia,Moore Dominic,Sharf Andrew,Irons Robert,Rao Kamakshi,Serody Jonathan,Coghill Jay,Gabriel Donald,Shea Thomas

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. CIBMTR summary slides part 1;Pasquini;CIBMTR Newslett,2006

2. Mobilization of autologous peripheral blood hematopoietic cells for cellular therapy;Shea,2009

3. Improving stem cell mobilization strategies: future directions;Bensinger;Bone Marrow Transplant,2009

4. Factors that influence collection and engraftment of autologous peripheral blood stem cells;Bensinger;J Clin Oncol,1995

5. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100);Giralt;Leukemia,2009

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma;Frontiers in Immunology;2024-07-18

2. Steady-State Versus Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma: A Single-Center Study to Analyze Efficacy and Safety;Journal of Hematology;2024-06

3. Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001);Cancers;2023-09-28

4. Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma;Transfusion and Apheresis Science;2023-06

5. Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study;Haematologica;2023-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3